Literature DB >> 21084104

Human monoclonal antibodies to West Nile virus identify epitopes on the prM protein.

Amanda E Calvert1, Gavreel F Kalantarov, Gwong-Jen J Chang, Ilya Trakht, Carol D Blair, John T Roehrig.   

Abstract

Hybridoma cell lines (2E8, 8G8 and 5G12) producing fully human monoclonal antibodies (hMAbs) specific for the pre-membrane (prM) protein of West Nile virus (WNV) were prepared using a human fusion partner cell line, MFP-2, and human peripheral blood lymphocytes from a blood donor diagnosed with WNV fever in 2004. Using site-directed mutagenesis of a WNV-like particle (VLP) we identified 4 amino acid residues in the prM protein unique to WNV and important in the binding of these hMAbs to the VLP. Residues V19 and L33 are important epitopes for the binding of all three hMAbs. Mutations at residue, T20 and T24 affected the binding of hMAbs, 8G8 and 5G12 only. These hMAbs did not significantly protect AG129 interferon-deficient mice or Swiss Webster outbred mice from WNV infection. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084104     DOI: 10.1016/j.virol.2010.10.033

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Degrees of maturity: the complex structure and biology of flaviviruses.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Curr Opin Virol       Date:  2012-03-23       Impact factor: 7.090

2.  Mutations in the West Nile prM protein affect VLP and virion secretion in vitro.

Authors:  Amanda E Calvert; Claire Y-H Huang; Carol D Blair; John T Roehrig
Journal:  Virology       Date:  2012-07-31       Impact factor: 3.616

3.  Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.

Authors:  Kimberly A Dowd; Swati Mukherjee; Richard J Kuhn; Theodore C Pierson
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

Review 4.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

Review 5.  The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis.

Authors:  Franz X Heinz; Karin Stiasny
Journal:  Microbiol Mol Biol Rev       Date:  2017-02-08       Impact factor: 11.056

6.  A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus.

Authors:  Tsai-Yu Lin; Kimberly A Dowd; Carolyn J Manhart; Steevenson Nelson; Stephen S Whitehead; Theodore C Pierson
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

7.  Mechanism and significance of cell type-dependent neutralization of flaviviruses.

Authors:  Swati Mukherjee; Kimberly A Dowd; Carolyn J Manhart; Julie E Ledgerwood; Anna P Durbin; Stephen S Whitehead; Theodore C Pierson
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

8.  Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.

Authors:  Lo Vang; Christopher S Morello; Jason Mendy; Danielle Thompson; Darly Manayani; Ben Guenther; Justin Julander; Daniel Sanford; Amit Jain; Amish Patel; Paul Shabram; Jonathan Smith; Jeff Alexander
Journal:  PLoS Negl Trop Dis       Date:  2021-03-12

9.  Monoclonal antibodies to Cache Valley virus for serological diagnosis.

Authors:  Benjamin Skinner; Sierra Mikula; Brent S Davis; Jordan A Powers; Holly R Hughes; Amanda E Calvert
Journal:  PLoS Negl Trop Dis       Date:  2022-01-24

Review 10.  B cell response and mechanisms of antibody protection to West Nile virus.

Authors:  S Kyle Austin; Kimberly A Dowd
Journal:  Viruses       Date:  2014-03-03       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.